📝 Results of a @GoHealio survey show that more than 70% of health care professionals use AI tools in their practices.
However, more than one-quarter of respondents do not have a formal AI policy in their practices.
Learn more 👇
https://t.co/IY24neuhqh
❗CMS has issued an interim final rule that implements new #workrequirements for adults on #Medicaid. Experts expressed concerns about the new rule, particularly medical frailty exemptions.
🔗Read more, with insight from @DarshaliVyas and @ArthurCaplan: https://t.co/3iPcuvK6Wd
Gendered differences may impact how medical students rank their preferred schools when matching for #residency, according to study data from @uclaanderson.
Learn more @GoHealio
https://t.co/QKX5RmjZxF
Heart-2 trial🗝️takeaways:
❤️ VERVE-102 safely lowered PCSK9 and LDL in patients with FH or premature CAD
🧬 Genetic base editing may represent a lifelong solution to reducing ASCVD risk in this population
@NEJM#EASCongress2026@EndocrineToday
https://t.co/n3cKEwrdGU
Inhaled insulin is finally FDA approved for children age over 6. That’s a great option for children who miss injections for boluses or wants freedom and privacy. People should need more options for type 1 diabetes @MannKindCorp
3 green tiles! Are you finishing it? 👀 There’s only one way to find out.
Play today’s WORD DOC and prove it: https://t.co/sstT4YvM5R
#WordGame#DailyPuzzle#HealthcareFun#WORDDOC
♀️ Wegovy induced weight loss and heart-related benefits for women with #obesity, regardless of menopausal status, according to data from two post hoc analyses presented at #ECO2026.
@EASOobesity @dremiliahuvinen @CardiologyToday@GoHealio@healiowomen
https://t.co/Jf7IOuGTYO
🗣️ “We can see whether their glucose level at this stage of being asymptomatic persists or whether glucose decompensates in the people who go on to develop #hantavirus infections.”
Read more ⬇️
@SutterHealth@InfectDisNews@DiabetesTechSoc@GoHealio
https://t.co/GNak0QZb9w
🗣️ Read more from @Drhkakturk of @CUAnschutz as he discusses a clinical trial assessing use of ultra-rapid insulin lispro-aabc with MiniMed 780G.
Read the full story on the study ⬇️
@IDinChildren@GoHealio
https://t.co/MHColLxEE3
🫁 Afrezza, an inhaled form of insulin, was originally approved for adults with type 1 or type 2 #diabetes in 2014.
Yesterday, the @US_FDA expanded the approval to children and teens aged 6 years and older.
@MannKindCorp@IDinChildren@GoHealio
https://t.co/hgd9MJ4muH
Public health data changes fast. Are you keeping up?
See for yourself and ask Healio AI the following prompt:
“How many confirmed measles cases have there been in the United States in 2026?”
Ask about measles: https://t.co/yaaJ4DZYWi
#HealioAI#PublicHealth#MedicalUpdates
📣 Hear from @Sara_Sleep as she discusses a pilot study that examined the benefits of cognitive behavioral therapy for women experiencing menopause-related insomnia and hot flashes.
Read the full story ⬇️
@BCMDeptMedicine@MenopauseJrnl
https://t.co/9FFsM12xVi
🚨 The @US_FDA has approved Afrezza for children and adolescents with type 1 or type 2 #diabetes, according to an announcement from @MannKindCorp.
Learn more about this new approval ⬇️
@IDinChildren@GoHealio
https://t.co/8iKNWVuSum
💉 Among people with type 1 diabetes using an ultra-rapid-acting insulin and optimal settings on the MiniMed 780G, a glucose management indicator of less than 7% was achieved by
📌 64% of children
📌 90% of adults
@Drhkakturk@CUAnschutz@IDinChildren
https://t.co/uTJbH0rbbe